Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Why Goldman Sachs says investors should buy the dip in U.S. tech stocks
Monday’s trillion-dollar stock-market wipeout will be remembered as an opportunity to scoop up shares of some of the most valuable U.S. companies at a discount, according to a team of equity strategists at Goldman Sachs Group.
All Eyes on Microsoft Stock Ahead of Earnings; Here’s What Goldman Sachs Expects
Microsoft (NASDAQ:MSFT) has lagged behind the NASDAQ over the past year but is off to a strong start in 2025, outperforming the broader market.
DeepSeek is a ‘wake up call’ to buy more stocks, says Goldman Sachs
DeepSeek’s breakthrough is “a wake up call” that adds to market concentration risks, Oppenheimer and team say: a reminder that benefits from any revolutionary technology don’t automatically accrue to big spenders at the start of the adoption cycle, and that competition humbles even the biggest companies.
Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product revenue guidance in six months.
Why Goldman Sachs says the DeepSeek plunge doesn't point to the start of a big stock market correction
"In our view this is a correction and not the start of a sustained bear market," Goldman Sachs said. DeepSeek sparked a $1 trillion market rout on Monday.
Goldman Sachs maintains Microsoft stock Buy rating, $500 target
Goldman Sachs reiterated its Buy rating and $500.00 price target for Microsoft Corporation (NASDAQ:MSFT), following the company's mixed financial results for the second quarter of fiscal year 2025. The investment firm pointed to the ongoing investor concerns over the growth pace of Microsoft's Azure cloud services,
Moderna stock drops as Goldman Sachs cuts rating
Moderna (NASDAQ:MRNA) shares about 3% ahead of Wednesday market open after Goldman Sachs (NYSE:GS) cut its rating on the stock to Neutral from Buy.
15d
on MSN
Goldman Sachs Surges Past Q4 Forecasts
Goldman Sachs Group outperformed expectations in its fourth-quarter and full-year earnings with a robust financial showing across all segments.
2h
Whirlpool Inventory Reduction, Low Discretionary Spending Led To Q4 Revenue Miss, Says Analyst
Whirlpool posts Q4 results that exceeded estimates, with adjusted EPS of $4.57, driven by a lower tax rate and interest ...
15d
on MSN
There's been a ‘meaningful shift' in CEO confidence since Trump's election, says Goldman's Solomon
The Wall Street CEO discussed growing confidence among business leaders after his bank’s strong fourth-quarter report.
Barron's
7d
Goldman Sachs Commodity Index Apr 2025
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
15d
Bank earnings: JPMorgan, Wells Fargo, Goldman Sachs post beats, and Citi swings to a profit
JPMorgan, Wells Fargo, Goldman Sachs and Citi are kicking off earnings season on Wednesday with their December-quarter results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback